Titre :
  • Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
Auteur : Herbrecht, R ; Maertens, J. ; Baila, L. ; Aoun, Michel ; Heinz, W ; Martino, Robert ; Schwartz, S. ; Ullmann, Andrew ; Meert, L ; Paesmans, Marianne ; Marchetti, Oscar ; Akan, Hamdi ; Ameye, Lieveke ; Shivaprakash, M ; Viscoli, Claudio
Informations sur la publication : Bone marrow transplantation, 45, 7, (page 1227-1233)
Statut de publication : Publié, 2010-07
Sujet CREF : Cancérologie
Mots-clés MeSH : Adult
Aged
Antifungal Agents -- therapeutic use
Aspergillosis -- drug therapy -- mortality
Drug Therapy, Combination
Drug Toxicity
Echinocandins -- administration & dosage -- therapeutic use -- toxicity
Europe
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation -- adverse effects -- methods -- mortality
Humans
Male
Middle Aged
Survival Rate
Transplantation, Homologous
Treatment Outcome
Young Adult
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0268-3369 
info:doi/10.1038/bmt.2009.334
info:pii/bmt2009334
info:pmid/20062093